Research ArticleNuclear Oncology
Imaging Prostate Cancer with Technetium-99m-7E11-C5.3 (CYT-351)
Vaseem U. Chengazi, Mark R. Feneley, David Ellison, Maria Stalteri, Arthur Granowski, Marie Granowska, Cyril C. Nimmon, Stephen J. Mather, Roger S. Kirby and Keith E. Britton
Journal of Nuclear Medicine May 1997, 38 (5) 675-682;
Vaseem U. Chengazi
Mark R. Feneley
David Ellison
Maria Stalteri
Arthur Granowski
Marie Granowska
Cyril C. Nimmon
Stephen J. Mather
Roger S. Kirby
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Imaging Prostate Cancer with Technetium-99m-7E11-C5.3 (CYT-351)
Vaseem U. Chengazi, Mark R. Feneley, David Ellison, Maria Stalteri, Arthur Granowski, Marie Granowska, Cyril C. Nimmon, Stephen J. Mather, Roger S. Kirby, Keith E. Britton
Journal of Nuclear Medicine May 1997, 38 (5) 675-682;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors
- Expression of Prostate-specific Membrane Antigen in Transitional Cell Carcinoma of the Bladder: Prognostic Value?
- Pretreatment with a Monoclonal Antibody/Interleukin-2 Fusion Protein Directed against DNA Enhances the Delivery of Therapeutic Molecules to Solid Tumors